Clinical trials in Moldova, Republic of
238 studies list at least one site in Moldova, Republic of. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2025-06-04.
Get an email when these change. Save the studies in Moldova, Republic of recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Most studied here
Who runs them
Bayer (11) · Janssen Research & Development, LLC (9) · Galapagos NV (8) · Gynuity Health Projects (7) · Pfizer (6) · UCB Biopharma SRL (5) · Alios Biopharma Inc. (5) · Can-Fite BioPharma (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 238 — search for more.
- Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisRecruitingNCT05201404Phase 3
- Efficacy and Safety of KBP-336 in Obese Individuals with OsteoarthritisRecruitingNCT06833749Phase 2
- Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)RecruitingNCT06277037
- Validation of the European Oncology Quality of Life ToolkitNot yet recruitingNCT05947903
- Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)RecruitingNCT04697810Phase 2
- PEA vs. Placebo for Major DepressionRecruitingNCT06063369Phase 2
- A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)CompletedNCT04712669Phase 2
- A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002)CompletedNCT03744637Phase 1
- Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006)CompletedNCT04370873Phase 1
- A Study of JNJ-67484703 in Participants With Active Rheumatoid ArthritisCompletedNCT04985812Phase 1
- Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the CommunityCompletedNCT04947475Not applicable
- A Study of JNJ-61393215 in the Treatment of DepressionCompletedNCT04080752Phase 2
- An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious DistressCompletedNCT02498392Phase 2
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus ErythematosusCompletedNCT05155345Phase 1
- A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of DepressionCompletedNCT03559192Phase 2
- A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric CancerCompletedNCT02795988Phase 1/2
- New Generation IGRA in Immunocompromised IndividualsCompletedNCT02639936
- Study of Evobrutinib in Participants With RMS (evolutionRMS 2)TerminatedNCT04338061Phase 3
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04200456Phase 3
- Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of BurnsCompletedNCT04152096Phase 4
- A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque PsoriasisCompletedNCT05728489Phase 1
- The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical TrialTerminatedNCT06568302Phase 3
- The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)CompletedNCT04073498Phase 1/2
- A Study of Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)CompletedNCT02662712Phase 1
- A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus ErythematosusCompletedNCT02609789Phase 1
- Assessment of Multifocal Continuous Theta Burst Transcranial Magnetic Stimulation (cTBS) Effects in Generalized Epilepsy Patients.CompletedNCT06797791Not applicable
- Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1a)CompletedNCT05085977Phase 1
- A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100CompletedNCT01534052Phase 2
- A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)Active, not recruitingNCT06041269Phase 2
- A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate CancerCompletedNCT04094519Phase 1
- A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateCompletedNCT05604885Phase 2
- A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseCompletedNCT02218099Phase 1/2
- Study to Investigate the Effect of Rifampin and Itraconazole on the Action of Pamiparib in Participants With CancerCompletedNCT03994211Phase 1
- A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT02867306Phase 1
- Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)CompletedNCT03852433Phase 2
- Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685CompletedNCT05332704Phase 1
- Evaluation of ADG20 for the Prevention of COVID-19TerminatedNCT04859517Phase 2/3
- Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4CompletedNCT04246762Phase 1
- Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)CompletedNCT04799249Phase 3
- Drug-drug Interaction Study With AZD5305 and Itraconazole in Patients With Advanced Solid MalignanciesCompletedNCT05573724Phase 1
- Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis ParticipantsCompletedNCT02065700Phase 2
- Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing RegimenTerminatedNCT04549025Phase 2
- Family-Focused Adolescent & Lifelong Health PromotionCompletedNCT05930535Not applicable
- Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia BCompletedNCT03855280Phase 3
- Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple SclerosisActive, not recruitingNCT05054140Phase 2
- A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB SubjectsTerminatedNCT05561530Phase 1
- IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS StudyActive, not recruitingNCT05417269Phase 1/2
- Study of M5049 in CLE and SLE ParticipantsCompletedNCT04647708Phase 1
- Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)TerminatedNCT03943550Phase 1
- An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)CompletedNCT05084261Phase 1